Page 22 - Vidant Health
P. 22
Complex large claims management and
stop-loss
Actionable cost containment opportunities
SPECIALTY ORGAN AND
PHARMACY TISSUE IMPLANTS
Clinical strategies:
Diagnosis conirmation
Treatment alternatives
ACTIONABLE Provider optimization
OPPORTUNITIES Pricing negotiation HIGH RISK
DEFINED ONCOLOGY PREGNANCY AND
Predetermined set of medical Treatment protocol
diagnostic categories where Rx cost containment NEONATAL
known impact can be made
Claim audit and re-pricing
Plan design recommendations
Site of care review
Domestic steerage
ESRD/DIALYSIS HEMOPHILIA
Vidant Health — Lockton Total Rewards Practice overview 22 Lockton Companies
stop-loss
Actionable cost containment opportunities
SPECIALTY ORGAN AND
PHARMACY TISSUE IMPLANTS
Clinical strategies:
Diagnosis conirmation
Treatment alternatives
ACTIONABLE Provider optimization
OPPORTUNITIES Pricing negotiation HIGH RISK
DEFINED ONCOLOGY PREGNANCY AND
Predetermined set of medical Treatment protocol
diagnostic categories where Rx cost containment NEONATAL
known impact can be made
Claim audit and re-pricing
Plan design recommendations
Site of care review
Domestic steerage
ESRD/DIALYSIS HEMOPHILIA
Vidant Health — Lockton Total Rewards Practice overview 22 Lockton Companies